Syphilis Diagnosis and Treatment Guideline
Clinical Significance of VDRL/RPR Titer
- A titer of 1:32 is highly specific for genuine syphilis infection, as false-positive results are extremely rare at titers ≥1:8, according to the Centers for Disease Control and Prevention 1
- This titer level indicates active, untreated disease rather than past treated infection, as successfully treated patients typically show fourfold declines in titer over 6-24 months, as recommended by the Centers for Disease Control and Prevention 2, 3
- The titer magnitude correlates with disease activity and infectiousness, particularly in early syphilis stages, as reported by the Centers for Disease Control and Prevention 4
Neurosyphilis Risk Assessment
- Some specialists recommend CSF examination for all patients with latent syphilis and nontreponemal titers >1:32, though this remains controversial, according to the Centers for Disease Control and Prevention 2
- In HIV-infected patients specifically, RPR titers ≥1:32 are associated with increased risk of CSF abnormalities and neurosyphilis, particularly when CD4 counts are ≤350 cells/mL, as reported by the Centers for Disease Control and Prevention 3
Staging and Treatment Implications
- For early syphilis, the American College of Physicians recommends treatment with benzathine penicillin G 2.4 million units IM as a single dose, with expected fourfold decline in titer within 6-12 months as evidence of treatment success, as recommended by the Centers for Disease Control and Prevention 1, 2, 3
- For late latent syphilis, the American College of Physicians recommends treatment with benzathine penicillin G 2.4 million units IM once weekly for 3 consecutive weeks, with expected fourfold decline in titer within 12-24 months, as recommended by the Centers for Disease Control and Prevention 1, 2, 3
- If neurosyphilis is confirmed, the Infectious Diseases Society of America recommends treatment with aqueous crystalline penicillin G 18-24 million units per day IV for 10-14 days, as recommended by the Centers for Disease Control and Prevention 1
Critical Clinical Actions Required
- Determine the stage of syphilis through history and physical examination, as recommended by the American College of Physicians 1
- Assess for neurosyphilis indications requiring immediate CSF examination, including neurologic symptoms, ophthalmic symptoms, evidence of tertiary syphilis, HIV infection with late latent or unknown duration syphilis, and treatment failure, as recommended by the Centers for Disease Control and Prevention 1, 2, 3
- Test for HIV infection, as all patients with syphilis should be screened, as recommended by the Centers for Disease Control and Prevention 1
- Initiate stage-appropriate penicillin therapy immediately unless contraindicated, as recommended by the American College of Physicians 1, 2, 3
- Arrange follow-up serologic monitoring at 6, 12, and 24 months, as recommended by the Centers for Disease Control and Prevention 1, 2, 3
Important Caveats
- Sequential testing must use the same method and preferably the same laboratory, as RPR titers are often slightly higher than VDRL titers and cannot be directly compared, as reported by the Centers for Disease Control and Prevention 1, 2, 4
- Treatment failure should be suspected if the titer fails to decline fourfold within the expected timeframe or if there is a sustained fourfold increase after initial decline, as recommended by the Centers for Disease Control and Prevention 1, 2, 3